Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

AUGUST 12, 2021

Net loss for the six months ended 30 June 2021 was $30.2 Net loss for the six months ended 30 June 2021 was $30.2 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. The analogy would be this. million, or $0.79

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. As it sits, only a few methods of treating autism are available.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

NOVEMBER 29, 2021

State legislators in 2021 enacted over 50 laws liberalizing marijuana policies in more than 25 states, according to a report issued today by the National Organization of the Reform of Marijuana Laws (NORML). 2021 was a significant year for marijuana policy reform. The law took effect on July 1, 2021. FULL REPORT. New Jersey.

Legislation 98

Legislation Patients Retail Access 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.)

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JULY 12, 2021

July 5, 2021 – July 9, 2021. CSE: MSET) revealed additional preclinical data showing strong efficacy and improved safety in a head-to-head comparison with psilocybin. PsyIndex Weekly Update. The PsyIndex moved marginally lower last week, giving up some gains from the prior week. Market Performance. Powered by.

Treatment 66

Treatment Decriminalization Pharmaceutical Data 66

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. 19 August 2021. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Medicinal cannabis Special Access Scheme category B data.

Data 105

Data Access Medicine Patients 105

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE:

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. Even if there’s an accurate diagnosis, many mental health treatments have less-than-desirable efficacy, and there can be significant side effects.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

NORML

DECEMBER 6, 2019

The decrim process requires no arrest, no handcuffs, no custody, no court, no jail, no supervision, no treatment, and no permanent record. According to recent data released by ACLU-NJ, marijuana possession arrests have risen 35% in just four years. Fines are usually between $25-$100.

Decriminalization 171

Decriminalization Policy Legislation Cannabis 171

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. The Marijuana Regulatory Agency issued a request for proposals for the 2021 Veteran Marijuana Research Grant Program on Tuesday, June 1. Between Dec.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

The Cannigma

MARCH 2, 2021

They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. While medical marijuana is a legal treatment option in 33 states and Washington D.C., Pain management was mentioned by 7.8%

Research and Development 145

Research and Development Treatment Chronic Pain Sleep 145

Cannabis Law Report

JUNE 1, 2021

TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — via InvestorWire – RYAH Group, Inc. The 5-year study is expected to cover tens of thousands of patients suffering from chronic pain, which makes it one of the largest and most ambitious research projects to be conducted in the plant-based treatment arena. Forward-Looking Statements.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

DECEMBER 26, 2021

Published: Dec 21, 2021. 21, 2021 /PRNewswire/ — Ixtlan Bioscience , a biotech company focused on developing psilocybin-based treatment for Alzheimer’s Disease and Brain Pathologies, has announced today the filing of a new Provisional Patent with the United States Patent and Trademark Office (USPTO) Application No.

Treatment 52

Treatment Patients Data Access 52

The Cannigma

JUNE 13, 2021

Published in “Front Psychiatry” in May 2021, the study examined 170 chronic cannabis users — defined as people who have used cannabis more than 100 times — and found that, relative to a control group, the cannabis users had smaller cerebellum volume and poorer self-reported sleep quality, and these effects were driven by the female cannabis users 1.

Sleep 143

Sleep Data Cannabis THC 143

Cannabis Law Report

JUNE 23, 2021

TORONTO, June 23, 2021 (GLOBE NEWSWIRE) — RYAH Group, Inc. “We are excited to be initiating our pilot program with Medicann in Jersey, which represents a unique, ‘ring-fenced’ environment for establishing potentially numerous studies on the efficacy of treatments using plant-based therapies. About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.

Business 81

Business Research and Development Environment Food 81

LifeCannMD

MAY 27, 2025

What really opened my eyes was this study that came out in 2021. Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. times more likely to achieve their treatment goals with medical cannabis.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Veriheal

MAY 16, 2022

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. and Torsten Falk, Ph.D.,

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Cannabis Law Report

SEPTEMBER 15, 2021

More than 100 people in the US have been hospitalized in 2021 after using Delta-8 THC products, federal health regulators warned Tuesday. National poison control centers received 661 exposure cases of delta-8 THC products between January 2018 and July 31, 2021, 660 of which occurred between January 1, 2021, and July 31, 2021.

THC 105

THC Pets Events Hemp 105

TheAnswerPage

NOVEMBER 19, 2021

According to a study published in the October 2021 edition of Cancer, what is the most common time for breast cancer patients to use cannabinoid-based products: pre-treatment, during treatment or after treatment? 24% used the cannabinoids pre-treatment, 79% during treatment and 54% after treatment.

Treatment 40

Treatment Cannabinoids Data Patients 40

The Cannigma

SEPTEMBER 13, 2021

In July, 2021, Israeli lawmakers rejected a bill that would have decriminalized recreational marijuana use. Also in 2020, Israel surpassed Germany as the world’s largest importer of medical cannabis flower, according to data from Israel’s online Cannabis Magazine. Can foreigners access medical marijuana?

Legalization 124

Legalization Decriminalization Patients Cannabis 124

Cannabis Law Report

AUGUST 2, 2021

CHICAGO , July 15, 2021 /PRNewswire/ — P alo Santo , the leading U.S.-based In 2020, founders Daniel Goldberg , Tim Schlidt and Tony Eisenberg partnered to form Palo Santo, and formally launched the venture capital fund in 2021. Here’s the press release. Tweet this.

Research and Development 98

Research and Development Therapy Collective Treatment 98

Veriheal

JANUARY 4, 2021

In adults with chronic pain , what are the harms of Kratom or other plant-based substances for treatment of chronic pain? In adults with chronic pain, what are the benefits of Kratom or other plant-based substances for treatment of chronic pain? In adults with chronic pain, what are the harms of cannabinoids? A Statement from the AHRQ.

Chronic Pain 105

Chronic Pain Therapy Cannabinoids Treatment 105

Canna Law Blog

JANUARY 10, 2020

Per the press release: Newsom intends to combine all three California cannabis agencies into one single Department of Cannabis Control by July 2021. million will be available for youth education, prevention, early intervention, and treatment; environmental protection; and public safety-related activities in 2020 and 2021.

Collective 95

Collective Retail Cultivation Agriculture 95

Cannabis Law Report

JUNE 7, 2021

As of May 2021, states reported a combined total of $7.9 Eight of the laws passed in 2020 or 2021, and in seven of those states, licensing and tax collections have not yet begun. As of April 2021, $404.5 million as of April 2021. April 2021. March 2021. Also, until July 2017, a 2.9% 46,104,922. 104,759,961.

Marijuana 91

Marijuana Retail Collective Programs 91

Cannabis Law Report

JULY 29, 2021

July 29, 2021 07:29 AM Eastern Daylight Time. Our second quarter results were a strong validation of our strategy as we posted a 250% quarter-over-quarter increase in revenue compared to the first quarter of 2021. TORONTO–( BUSINESS WIRE )–Heritage Cannabis Holdings Corp. Eastern Canada.

Recreational 98

Recreational Vaping Concentrates Clinical Trials 98

Cannabis Law Report

SEPTEMBER 1, 2021

As of start of business Wednesday, September 1, the Commission reported licensees have generated $844 million since January 1, already making 2021 a record sales year thus far. The Commission’s overall staff has increased to 84 employees, with 17 new employees joining the agency in 2021 and spanning nearly every department.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In

Clinical Trials 40

Clinical Trials Research and Development Data Patients 40

Cannabis Law Report

JULY 22, 2021

VANCOUVER, BC, July 22, 2021 /CNW/ – Levitee Labs Inc. A review of the Company’s recent achievements and current business is as follows: On July 14 th , 2021, Levitee launched its premium mushroom supplement blends MONKE into the North American market on major eCommerce platforms, including Amazon. About Levitee Labs.

eCommerce 105

eCommerce Therapy Media Access 105

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 81

CBD Data Sleep Clinical Trials 81

Cannabis Law Report

AUGUST 10, 2021

CSE: LOAN ) (FSE: O3X) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) (“Global” or the “Company”) is pleased to announce the signing of a definitive agreement on August 6th 2021 memorializing the Global Wellness Strategies , Inc. binding letter of intent signed on July 12th 2021 to purchase certain assets of Cannvalate Pty Ltd. (“CV”)

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

SEPTEMBER 12, 2021

September 09, 2021. Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Earlier this year, Gov.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

Cannabis Law Report

JULY 6, 2021

July 06, 2021 08:30 ET | Source: Ehave. MIAMI, July 06, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Dr. Bankole Johnson was featured in a March 5 th 2021 Forbes article, “Dr. A replay of the interview is available on the media section of the Company’s website at: [link]. ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

JULY 19, 2021

July 19, 2021 07:58 ET | Source: Potbotics, Inc. Toronto, July 19, 2021 (GLOBE NEWSWIRE) — via InvestorWire — RYAH Group, Inc. This is a precedent-setting experiment that is expected to generate the data needed to facilitate an accurate milligram dosing experience with dry herb.”. billion by 2027.

Therapy 76

Therapy Data Research and Development Pharmaceutical 76

Cannabis Law Report

NOVEMBER 26, 2021

(NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended September 30, 2021. On September 30, 2021, Can-Fite had approximately $13.3 Fortified Balance Sheet.

Clinical Trials 40

Clinical Trials Research and Development Treatment Data 40